300534 陇神戎发
已收盘 04-30 15:00:00
资讯
新帖
简况
陇神戎发(300534.SZ)发布一季度业绩,净利润2214.1万元,增长10.68%
智通财经网 · 04-26
陇神戎发(300534.SZ)发布一季度业绩,净利润2214.1万元,增长10.68%
陇神戎发(300534.SZ)发布2023年度业绩,净利润6164.77万元 同比增加58.95%
智通财经 · 04-23
陇神戎发(300534.SZ)发布2023年度业绩,净利润6164.77万元 同比增加58.95%
陇神戎发(300534.SZ):深交所终止审核公司申请定增股票事项
智通财经网 · 03-26
陇神戎发(300534.SZ):深交所终止审核公司申请定增股票事项
陇神戎发拟募4.86亿破产能瓶颈 聚焦主业预期2025年营收逾15亿
市场资讯 · 01-09
陇神戎发拟募4.86亿破产能瓶颈 聚焦主业预期2025年营收逾15亿
陇神戎发拟定增募资近5亿元 “扩产”宣肺止嗽合剂
新京报 · 01-07
陇神戎发拟定增募资近5亿元 “扩产”宣肺止嗽合剂
【异动股】中药板块拉升,陇神戎发(300534.CN)涨10.13%
财华社 · 2023-11-24
【异动股】中药板块拉升,陇神戎发(300534.CN)涨10.13%
陇神戎发上涨5.89%,报11.5元/股
金融界网站 · 2023-11-24
陇神戎发上涨5.89%,报11.5元/股
加载更多
公司概况
公司名称:
甘肃陇神戎发药业股份有限公司
所属行业:
医药制造业
上市日期:
2016-09-13
主营业务:
甘肃陇神戎发药业股份有限公司从事的主要业务是医药产品、医疗产品、保健卫生产品的研究开发;中成药、保健食品、原料药、少量医药中间体、化学药品的生产和销售。主要产品元胡止痛滴丸、酸枣仁油滴丸、鞣酸小檗碱膜和七味温阳胶囊均为独家品种,公司主打产品元胡止痛滴丸二次开发研究项目目前已经形成系统性学术论文、发明专利并出版《元胡止痛滴丸二次开发》和《中药大品种质量标准提升研究》 2本专著,元胡止痛滴丸二次开发项目论文成功入选“第四届中国科协优秀科技论文”。宣肺止嗽合剂先后获得甘肃省科技进步三等奖、甘肃省药学会发展奖三等奖、甘肃省新产品新技术奖等奖项。
发行价格:
13.64
{"stockData":{"symbol":"300534","market":"SZ","secType":"STK","nameCN":"陇神戎发","latestPrice":8.23,"timestamp":1714460610000,"preClose":8.15,"halted":0,"volume":7340000,"delay":0,"floatShares":301000000,"shares":303000000,"eps":0.2103,"marketStatus":"已收盘","marketStatusCode":5,"change":0.08,"latestTime":"04-30 15:00:00","open":8.2,"high":8.28,"low":8.1,"amount":60230800,"amplitude":0.0221,"askPrice":8.23,"askSize":153,"bidPrice":8.22,"bidSize":427,"shortable":0,"etf":0,"ttmEps":0.2103,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":8.15,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":8.97,"lowLimit":7.34,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":303345000,"pbRate":3.77,"roa":"--","roe":"3.43%","epsLYR":0.2032,"committee":-0.37961,"marketValue":2497000000,"floatMarketCap":2476000000,"peRate":39.13457,"changeRate":0.0098,"turnoverRate":0.0244,"status":0},"requestUrl":"/m/hq/s/300534","defaultTab":"news","newsList":[{"id":"2430270942","title":"陇神戎发(300534.SZ)发布一季度业绩,净利润2214.1万元,增长10.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430270942","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2430270942?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:03","pubTimestamp":1714129394,"startTime":"0","endTime":"0","summary":"智通财经APP讯,陇神戎发(300534.SZ)发布2024年第一季度报告,该公司营业收入为2.55亿元,同比减少13.97%。归属于上市公司股东的净利润为2214.1万元,同比增长10.68%。归属于上市公司股东的扣除非经常性损益的净利润为2121.86万元,同比增长10.81%。基本每股收益为0.073元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111988.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429199840","title":"陇神戎发(300534.SZ)发布2023年度业绩,净利润6164.77万元 同比增加58.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429199840","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429199840?lang=zh_cn&edition=full","pubTime":"2024-04-23 20:15","pubTimestamp":1713874543,"startTime":"0","endTime":"0","summary":"智通财经APP讯,陇神戎发(300534.SZ)发布2023年年度业绩报告,报告期内公司实现营业收入10.8亿元,同比增加35.06%;归属于上市公司股东的净利润6164.77万元,同比增加58.95%;归属于上市公司股东的扣除非经常性损益的净利润5167.7万元,同比增加296.66%;基本每股收益0.2032元,公司拟向全体股东每10股派发现金红利0.20元(含税)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107898.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422660060","title":"陇神戎发(300534.SZ):深交所终止审核公司申请定增股票事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2422660060","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2422660060?lang=zh_cn&edition=full","pubTime":"2024-03-26 18:43","pubTimestamp":1711449780,"startTime":"0","endTime":"0","summary":"陇神戎发(300534.SZ)公告,公司和保荐人国泰君安证券股份有限公司于2024年3月21日向深交所提交了《甘肃陇神戎发药业股份有限公司关于撤回向特定对象发行股票申请文件的申请》和《国泰君安证券股份有限公司关于撤回甘肃陇神戎发药业股份有限公司向特定对象发行股票申请文件的申请》,申请撤回本次向特定对象发行股票的申请文件。近日,公司收到深交所出具的《关于终止对甘肃陇神戎发药业股份有限公司申请向特定对象发行股票审核的决定》,深交所决定终止对公司申请向特定对象发行股票的审核。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-26/doc-inapsark0409096.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-26/doc-inapsark0409096.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2402948228","title":"陇神戎发拟募4.86亿破产能瓶颈 聚焦主业预期2025年营收逾15亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2402948228","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2402948228?lang=zh_cn&edition=full","pubTime":"2024-01-09 08:02","pubTimestamp":1704758520,"startTime":"0","endTime":"0","summary":" 陇神戎发定增扩产计划取得新进展。 近日,深交所官网披露了陇神戎发药业股份有限公司以简易程序向特定对象发行股票募集说明书(申报稿),公司定增材料被正式受理。 长江商报记者注意到,依靠独家产品宣肺止嗽合剂和元胡止痛滴丸,陇神戎发持续聚焦主业,业绩9稳定增长,2023年前三个季度净利润同比大增192.27%。 随着进一步突破产能瓶颈,公司预计2023年至2025年,实现营业收入分别为9.91亿元、12.28亿元、15.21亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-01-09/doc-inaawrki7844713.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-01-09/doc-inaawrki7844713.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2401869471","title":"陇神戎发拟定增募资近5亿元 “扩产”宣肺止嗽合剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2401869471","media":"新京报","top":-1,"share":"https://www.laohu8.com/m/news/2401869471?lang=zh_cn&edition=full","pubTime":"2024-01-07 20:34","pubTimestamp":1704630840,"startTime":"0","endTime":"0","summary":"新京报讯 陇神戎发1月5日对外公告,拟向特定对象发行A股股票募资4.86亿元,将主要用于甘肃普安制药股份有限公司年产5000万盒(3亿支)宣肺止嗽合剂等液体制剂生产线升级改造项目。 上市募集资金扣除发行费用后将主要用于普安制药年产5000万盒(3亿支)宣肺止嗽合剂等液体制剂生产线升级改造项目、甘肃陇神戎发药业股份有限公司三化改造及合剂生产线配套建设项目、补充流动资金及偿还贷款。智能定投、条件单、个股雷达……","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-01-07/doc-inaateru9974021.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-01-07/doc-inaateru9974021.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2385605766","title":"【异动股】中药板块拉升,陇神戎发(300534.CN)涨10.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2385605766","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2385605766?lang=zh_cn&edition=full","pubTime":"2023-11-24 10:00","pubTimestamp":1700791228,"startTime":"0","endTime":"0","summary":"今日早盘,截至10:00,中药板块拉升。陇神戎发(300534.CN)涨10.13%报11.96元,特一药业(002728.CN)涨7.39%报20.19元,葫芦娃(605199.CN)涨7.17%报18.38元,大唐药业(836433.CN)涨6.80%报5.5元,香雪制药(300147.CN)涨6.18%报6.36元,众生药业(002317.CN)涨5.71%报19.44元,方盛制药(603998.CN)涨4.57%报11.89元,上海凯宝(300039.CN)涨3.84%报7.57元。","market":"hk","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/656003bc9dfc4250c48f3a4b","is_publish_highlight":false,"gpt_icon":0},{"id":"2385606813","title":"陇神戎发上涨5.89%,报11.5元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2385606813","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2385606813?lang=zh_cn&edition=full","pubTime":"2023-11-24 09:45","pubTimestamp":1700790300,"startTime":"0","endTime":"0","summary":"转自:金融界本文源自:金融界11月24日,陇神戎发盘中上涨5.89%,截至09:33,报11.5元/股,成交8350.45万元,换手率2.49%,总市值34.88亿元。公司拥有25个产品品种,其中包括24个中药准字号品种和1个保健食品品种,主打产品元胡止痛滴丸和宣肺止嗽合剂的年销售额均超过3亿元。截至11月20日,陇神戎发股东户数2.97万,人均流通股1.01万股。2023年1月-9月,陇神戎发实现营业收入8.12亿元,同比增长102.52%;归属净利润4682.77万元,同比增长192.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2023-11-24/doc-imzvssmy4754217.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2023-11-24/doc-imzvssmy4754217.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-09-13","address":"甘肃省兰州市榆中县定远镇国防路10号","stockEarnings":[{"period":"1week","weight":0.0484},{"period":"1month","weight":-0.0237},{"period":"3month","weight":0.0405},{"period":"6month","weight":-0.1636},{"period":"1year","weight":-0.2456},{"period":"ytd","weight":-0.1662}],"companyName":"甘肃陇神戎发药业股份有限公司","boardCode":"AI0027","perCapita":"9763股","boardName":"医药制造业","registeredCapital":"30334万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 甘肃陇神戎发药业股份有限公司从事的主要业务是医药产品、医疗产品、保健卫生产品的研究开发;中成药、保健食品、原料药、少量医药中间体、化学药品的生产和销售。主要产品元胡止痛滴丸、酸枣仁油滴丸、鞣酸小檗碱膜和七味温阳胶囊均为独家品种,公司主打产品元胡止痛滴丸二次开发研究项目目前已经形成系统性学术论文、发明专利并出版《元胡止痛滴丸二次开发》和《中药大品种质量标准提升研究》 2本专著,元胡止痛滴丸二次开发项目论文成功入选“第四届中国科协优秀科技论文”。宣肺止嗽合剂先后获得甘肃省科技进步三等奖、甘肃省药学会发展奖三等奖、甘肃省新产品新技术奖等奖项。","serverTime":1714800865245,"listedPrice":13.64,"stockholders":"30819人(较上一季度减少2.29%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"陇神戎发(300534)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供陇神戎发(300534)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"陇神戎发,300534,陇神戎发股票,陇神戎发股票老虎,陇神戎发股票老虎国际,陇神戎发行情,陇神戎发股票行情,陇神戎发股价,陇神戎发股市,陇神戎发股票价格,陇神戎发股票交易,陇神戎发股票购买,陇神戎发股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"陇神戎发(300534)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供陇神戎发(300534)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}